Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126838142 | 12683814 | 2 | F | 20160819 | 20160825 | 20160826 | EXP | GB-CONCORDIA PHARMACEUTICALS INC.-GSH201608-004143 | CONCORDIA | 62.00 | YR | F | Y | 0.00000 | 20160826 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126838142 | 12683814 | 1 | PS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | U | U | 21959 | ||||||||
| 126838142 | 12683814 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | U | U | 21959 | ||||||||
| 126838142 | 12683814 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | U | U | 21959 | ||||||||
| 126838142 | 12683814 | 4 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | U | U | 21959 | ||||||||
| 126838142 | 12683814 | 5 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | U | U | 21959 | ||||||||
| 126838142 | 12683814 | 6 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 7 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 8 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 9 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 10 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 11 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 12 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 13 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 14 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 15 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 16 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 17 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 18 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 19 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 20 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126838142 | 12683814 | 21 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126838142 | 12683814 | 1 | Diffuse large B-cell lymphoma |
| 126838142 | 12683814 | 6 | Diffuse large B-cell lymphoma |
| 126838142 | 12683814 | 9 | Diffuse large B-cell lymphoma |
| 126838142 | 12683814 | 14 | Diffuse large B-cell lymphoma |
| 126838142 | 12683814 | 17 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126838142 | 12683814 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126838142 | 12683814 | Diffuse large B-cell lymphoma | |
| 126838142 | 12683814 | Disease progression | |
| 126838142 | 12683814 | Kidney infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |